TRP Natural Eyes eye drops recalled due to lack of sterility assurance
TRP Natural Eyes Aging Eye Relief eye drops are being recalled because the manufacturer cannot assure the product meets sterility requirements. The recall affects 19,344 bottles distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a risk-of-harm product—eye drops require sterility due to direct contact with sensitive ocular tissue. No illnesses or injuries have been reported, but the lack of sterility assurance represents a serious potential hazard that meets the rubric criterion for high-severity recalls.
Plain-English summary
TRP Natural Eyes Aging Eye Relief, a homeopathic sterile eye drop product, is being recalled by Optikem International, Inc. The recall is due to lack of assurance of sterility—the manufacturer cannot confirm the product meets required sterility standards.
The recall affects 19,344 bottles with lot numbers G806 (expiration 06-01-2025) and G807 (expiration 10-27-2026). The affected product was distributed nationwide in the United States.
Consumers who have purchased this product should stop using it immediately. Anyone with questions or concerns should consult their healthcare provider or pharmacist.
The recalled product
- Product
- TRP Natural Eyes Aging Eye Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-027-15.
- Manufacturer
- Optikem International, Inc.
- Category
- Drug — Eye Drops / Ophthalmic
- Hazard
- sterility-failure
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: G806
- Exp: 06-01-2025
- G807
- Exp: 10-27-2026.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27